What is the problem you're trying to solve?
Personalized cancer therapy requires that doctors precisely localize the tumor throughout the course of therapy in order to eradicate it. Nanovista’s proprietary imaging agent platform leverages nanotechnology to provide continued visibility of the malignant tumor tissue before, during and after surgery. Our nano agent has the potential to significantly improve the precision of over 200 million cancer surgery procedures conducted each year around the world.
How is what you're doing different than other attempts to solve this problem?
As cancer diagnosis and screening improve, surgeons have the challenge of having to resect increasingly small tumors that are often invisible and non-palpable. Attempts that have tried to address this challenge relied on either implanting invasive objects to mark the location of the tumor or using non-specific imaging agents to provide some transient visibility requiring the patient to be injected and scanned multiple times over the course of the surgery. Nanovista’s technology enables effective tumor visualization using multiple imaging modalities following a single administration over the entire course of surgery from pre-operative planning to intra-operative guidance and post-operative assessment.
Why are you passionate about what you're working on?
My passion about Nanovista is fueled by my desire to help a high potential technology that has produced great results in our laboratories to reach clinical use and ultimately provide concrete benefits to cancer patients worldwide.
What achievement are you most proud of?
I am a scientist, an entrepreneur and a mother. Regardless of which hat I am wearing, I approach life with passion and perseverance. We live in an exciting time where innovation knows no boundary. I hope that my contributions will one day have a significant impact in helping patients conquer cancer.